Reviva Pharmaceuticals Holdings, Inc. ( RVPH) - Stock Earnings
RVPH Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
RVPH Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -3.4 million USD | — USD |
| 2026Q1 | -3.2 million USD | — USD |
| 2026Q2 | -2.4 trillion USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
RVPH Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -39.3 million USD | — USD |
| 2024 | -29.9 million USD | — USD |
| 2025 | -19.9 million USD | — USD |
| 2026 Est. | — | — |
RVPH
Price: $0.46
52 week price:
Earnings Per Share: -1.03 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 71600
Market Capitalization: 6.4 million